- Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
- Pulse Biosciences Announces Plans to Initiate a Rights Offering
- Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024
- Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
- Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
- Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium
More ▼
Key statistics
On Wednesday, Pulse Biosciences Inc (PLSE:NAQ) closed at 7.47, 97.62% above the 52 week low of 3.78 set on Oct 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.87 |
---|---|
High | 7.87 |
Low | 7.38 |
Bid | 7.18 |
Offer | 8.00 |
Previous close | 7.78 |
Average volume | 177.09k |
---|---|
Shares outstanding | 55.23m |
Free float | 16.36m |
P/E (TTM) | -- |
Market cap | 429.65m USD |
EPS (TTM) | -0.8936 USD |
Data delayed at least 15 minutes, as of Apr 17 2024 21:00 BST.
More ▼